Terms: = Thyroid cancer AND TG, Thyroglobulin AND Clinical Outcome
62 results:
1. The relationship between thyroid peroxidase antibody and differentiated thyroid cancer: a systematic review and meta-analysis.
Zhang H; Tian L; Wang X; Shi X
Front Endocrinol (Lausanne); 2024; 15():1349041. PubMed ID: 38476675
[TBL] [Abstract] [Full Text] [Related]
2. Long-term prognostic analysis of children and adolescents with differentiated thyroid carcinoma based on therapeutic response to initial radioiodine therapy.
Wang C; Lu G; Li Y; Liu X; Wang G; Lu C; Li J; Luo Q; Zhang Q; Sun M; Wang X; Wang R
Front Endocrinol (Lausanne); 2023; 14():1217092. PubMed ID: 37600705
[TBL] [Abstract] [Full Text] [Related]
3. No Association of Preablation thyroglobulin Antibody Positivity and outcome in Pediatric Patients With Papillary thyroid Carcinoma.
Xu Y; Shi L; Wu J; Li H; Wang Y; Liu B
Clin Nucl Med; 2023 Sep; 48(9):763-767. PubMed ID: 37385237
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of factors influencing the clinical outcome after surgery and
Li Y; Rao M; Zheng C; Huang J; Fang D; Xiong Y; Yuan G
Front Endocrinol (Lausanne); 2022; 13():1015798. PubMed ID: 36313750
[TBL] [Abstract] [Full Text] [Related]
5. Is multifocality a risk factor in low-risk papillary thyroid cancer?
Sapuppo G; Grasso S; Di Benedetto G; Marturano I; Costanzo G; Belfiore A; Pellegriti G
Endokrynol Pol; 2022; 73(6):928-934. PubMed ID: 36094871
[TBL] [Abstract] [Full Text] [Related]
6. Role of Prophylactic Central Compartment Lymph Node Dissection on the outcome Of Patients With Papillary thyroid Carcinoma and Synchronous Ipsilateral Cervical Lymph Node Metastases.
De Napoli L; Matrone A; Favilla K; Piaggi P; Galleri D; Ambrosini CE; Aghababyan A; Papini P; Valerio L; Viola D; Torregrossa L; Ugolini C; Proietti A; Basolo F; Miccoli P; Elisei R; Materazzi G
Endocr Pract; 2020 Aug; 26(8):807-817. PubMed ID: 33471672
[TBL] [Abstract] [Full Text] [Related]
7. thyroglobulin Antibodies as a Prognostic Factor in Papillary thyroid Carcinoma Patients with Indeterminate Response After Initial Therapy.
Landenberger GMC; de Souza Salerno ML; Golbert L; de Souza Meyer EL
Horm Metab Res; 2021 Feb; 53(2):94-99. PubMed ID: 32886943
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone administration for adjuvant therapy in patients with intermediate- to high-risk differentiated thyroid cancer.
Iizuka Y; Katagiri T; Ogura K; Inoue M; Nakamura K; Mizowaki T
Ann Nucl Med; 2020 Oct; 34(10):736-741. PubMed ID: 32643022
[TBL] [Abstract] [Full Text] [Related]
9. Lymphocyte-to-monocyte ratio prior to radioiodine ablation in low- and intermediate-risk, papillary thyroid cancer.
Kim K; Pak K; Kim IJ; Kim M; Kim BH; Lee BJ; Kim SJ
Endocrine; 2020 Nov; 70(2):364-371. PubMed ID: 32372305
[TBL] [Abstract] [Full Text] [Related]
10. DELAYED 131-I FIRST TREATMENT AFTER SURGERY HAS NO IMPACT ON THE MEDIAN TERM outcome OF PATIENTS WITH INTERMEDIATE RISK DIFFERENTIATED thyroid cancer.
Matrone A; Gambale C; Torregrossa L; Piaggi P; Bianchi F; Valerio L; Viola D; Agate L; Molinaro E; Materazzi G; Basolo F; Vitti P; Elisei R
Endocr Pract; 2020 Jan; 26(1):58-71. PubMed ID: 31557080
[No Abstract] [Full Text] [Related]
11. Radioguided occult lesion localization in patients with recurrent thyroid cancer.
Tuncel M; Süslü N
Eur Arch Otorhinolaryngol; 2019 Jun; 276(6):1757-1766. PubMed ID: 30887167
[TBL] [Abstract] [Full Text] [Related]
12. Falsely elevated thyroglobulin and calcitonin due to rheumatoid factor in non-relapsing thyroid carcinoma: A case report.
Lupoli GA; Barba L; Liotti A; La Civita E; Lupoli R; Riccio E; Portella G; Formisano P; Beguinot F; Terracciano D
Medicine (Baltimore); 2019 Feb; 98(5):e14178. PubMed ID: 30702570
[TBL] [Abstract] [Full Text] [Related]
13. BRAF V600E and Retinoic Acid in Radioiodine-Refractory Papillary thyroid cancer.
Groener JB; Gelen D; Mogler C; Herpel E; Toth C; Kender Z; Peichl M; Haufe S; Haberkorn U; Sulaj A; Zemva J; Kopf S; Nawroth PP; Brune M; Rudofsky G
Horm Metab Res; 2019 Jan; 51(1):69-75. PubMed ID: 30396219
[TBL] [Abstract] [Full Text] [Related]
14. Increased Numbers of Circulating Tumor Cells in thyroid cancer Patients.
Ehlers M; Allelein S; Schwarz F; Hautzel H; Kuebart A; Schmidt M; Haase M; Dringenberg T; Schott M
Horm Metab Res; 2018 Aug; 50(8):602-608. PubMed ID: 30081408
[TBL] [Abstract] [Full Text] [Related]
15. Fractionated dosage of radioiodine for the ablation of low-risk differentiated thyroid cancer has no impact on survival.
Woliński K; Czepczyński R; Stangierski A; Trojanowski M; Rewaj-Łosyk M; Ziemnicka K; Bączyk M; Dyzmann-Sroka A; Ruchała M
Endokrynol Pol; 2018; 69(3):230-234. PubMed ID: 29504625
[TBL] [Abstract] [Full Text] [Related]
16. Delayed initial radioiodine therapy related to incomplete response in low- to intermediate-risk differentiated thyroid cancer.
Li H; Zhang YQ; Wang C; Zhang X; Li X; Lin YS
Clin Endocrinol (Oxf); 2018 Apr; 88(4):601-606. PubMed ID: 29338092
[TBL] [Abstract] [Full Text] [Related]
17. clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer.
Lin B; Qiang W; Wenqi Z; Tianyu Y; Lina Z; Bin J
Nucl Med Commun; 2017 Dec; 38(12):1036-1040. PubMed ID: 28953211
[TBL] [Abstract] [Full Text] [Related]
18. Recombinant human TSH stimulated thyroglobulin levels at remnant ablation predict structural incomplete response to treatment in patients with differentiated thyroid cancer.
Ha J; Kim MH; Jo K; Lim Y; Bae JS; Lee S; Kang MI; Cha BY; Lim DJ
Medicine (Baltimore); 2017 Jul; 96(29):e7512. PubMed ID: 28723762
[TBL] [Abstract] [Full Text] [Related]
19. Lenvatinib induces early tumor shrinkage in patients with advanced thyroid carcinoma.
Masaki C; Sugino K; Saito N; Saito Y; Tanaka T; Ogimi Y; Maeda T; Osaku T; Akaishi J; Hames KY; Tomoda C; Suzuki A; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Takami H; Ito K
Endocr J; 2017 Aug; 64(8):819-826. PubMed ID: 28659544
[TBL] [Abstract] [Full Text] [Related]
20. Dynamic Risk Estimates of outcome in Chinese Patients with Well-Differentiated thyroid cancer After Total thyroidectomy and Radioactive Iodine Remnant Ablation.
Shen FC; Hsieh CJ; Huang IC; Chang YH; Wang PW
Thyroid; 2017 Apr; 27(4):531-536. PubMed ID: 28007013
[TBL] [Abstract] [Full Text] [Related]
[Next]
